A Study of LY2484595 in Japanese Subjects
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.
Also called NCT01375075
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 165 participants
- Sponsor
- Registry
-
NCT01375075
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01375075. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2018-10-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of LY2484595 in Japanese Subjects
- Condition
- Dyslipidemias
- Intervention (Drug)
- LY2484595
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01375075- Content hash
ee86856810f822f1e94883dc6b5e7bcc32a1e39bc76aba26ab9d9d3440b7d29d